Pawlik M, Rommelspacher H
Department of Neuropsychopharmacology, Free University, Berlin, F.R.G.
Eur J Pharmacol. 1988 Mar 1;147(2):163-71. doi: 10.1016/0014-2999(88)90775-3.
Specific binding sites were demonstrated for some beta-carbolines in the rat brain with [3H]norharman as a ligand. The ligand displayed a high affinity for synaptosomal membranes which had been fractionated by a sucrose gradient. The calculated apparent KD value was 1.55 nmol/l and the maximum number of binding sites 148 fmol/mg protein. Displacement studies showed an exclusive specificity for a small group of beta-carbolines but not for the previously described inverse agonists at the benzodiazepine receptor nor for tryptamine and other indoles, as well as pargyline, a monoamine oxidase inhibitor. Further analysis revealed other binding sites for [3H]norharman, with an apparent KD value of 36 nmol/l that are presumably located on mitochondrial membranes. Binding to these sites was also not displaced by pargyline. Pargyline displaced [3H]norharman from a third population of binding sites on mitochondrial membranes with the apparent KD value of 46 nmol/l. These findings could explain the pharmacological effects of norharman and other beta-carbolines in vivo.
以[3H]去甲哈尔满作为配体,在大鼠脑中证实了某些β-咔啉的特异性结合位点。该配体对经蔗糖梯度分级分离的突触体膜具有高亲和力。计算得出的表观KD值为1.55 nmol/l,结合位点的最大数量为148 fmol/mg蛋白质。置换研究表明,对一小部分β-咔啉具有专一性,而对先前描述的苯二氮䓬受体反向激动剂、色胺和其他吲哚以及单胺氧化酶抑制剂帕吉林则没有专一性。进一步分析揭示了[3H]去甲哈尔满的其他结合位点,其表观KD值为36 nmol/l,推测位于线粒体膜上。帕吉林也不能置换与这些位点的结合。帕吉林以表观KD值46 nmol/l从线粒体膜上的第三类结合位点置换[3H]去甲哈尔满。这些发现可以解释去甲哈尔满和其他β-咔啉在体内的药理作用。